Skip to main content

Table 3 Optical Coherence Tomography Evaluation at 14 and 28-day

From: Polymer-free dual drug-eluting stents evaluated in a porcine model

   NA (mm2) P CSR% P
14 day
  BMS (n = 8) 1.46 (1.35,1.69) 0.708 37.67 (26.74,50.65) 0.011
PrES (n = 9) 1.56 (1.35,1.88) 53.24 (38.99,81.05)
SES (n = 7) 1.52 (1.16,1.61) 20.27 (13.49,25.95)
DDES(n = 8) 1.38 (1.34,1.56) 40.06 (14.12,50.16)
28 day
  BMS (n = 7) 2.57 (1.75,2.98) 0.300 93.64 (89.07,97.79) 0.644
PrES (n = 7) 2.23 (1.57,3.15) 92.77 (50.00,98.23)
SES (n = 7) 1.91 (1.49,2.30) 85.15 (84.94,100.00)
DDES(n = 6) 1.68 (1.54,2.40) 88.22 (64.24,94.56)
  1. NA Neointimal Area, CSR% Ratio of Covered Struts, BMS Bare-Metal Stents, PrES Probucol-Eluting Stents, SES Sirolimus-Eluting Stents, DDES Dual Drug-Eluting Stents